Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin

MLA

George Tannous, et al. “Therapeutic Success of Rifaximin for Clostridium Difficile Infection Refractory to Metronidazole and Vancomycin.” Case Reports in Gastroenterology, vol. 4, no. 3, Sept. 2010, pp. 404–09. EBSCOhost, https://doi.org/10.1159/000320685.

APA

George Tannous, Guy Neff, & Nyingi Kemmer. (2010). Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin. Case Reports in Gastroenterology, 4(3), 404–409. https://doi.org/10.1159/000320685

Chicago

George Tannous, Guy Neff, and Nyingi Kemmer. 2010. “Therapeutic Success of Rifaximin for Clostridium Difficile Infection Refractory to Metronidazole and Vancomycin.” Case Reports in Gastroenterology 4 (3): 404–9. doi:10.1159/000320685.